Publications
- Multicentered patient-based evidence of the role of free light chain ratio normalization in multiple myeloma disease relapse2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study2016 | Publication without faculty affiliation
- Subcutaneous Bortezomib in Multiple Myeloma Patients Induces Similar Therapeutic Response Rates as Intravenous Application But It Does Not Reduce the Incidence of Peripheral Neuropathy2015 | Third Faculty of Medicine
- Low and high risk monoclonal gammopathy of undetermined signifikance: analysis outcomes of RMG registry Czech Myeloma Group for practice2015 | Publication without faculty affiliation
- Diagnosis and treatment of multiple myeloma2014 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
- Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report2012 | First Faculty of Medicine
- Similar efficacy of thalidomide- and bortezomib-based regimens for first relapse of multiple myeloma2011 | First Faculty of Medicine
- Retrospective Analysis of the Results of High-dose Chemotherapy with the Support of Autologous Blood Stem Cells in Patients with Multiple Myeloma. The Experience of a Single Centre2010 | First Faculty of Medicine
- Retrospective Analysis of the Results of High-dose Chemotherapy with the Support of Autologous Blood Stem Cells in Patients with Multiple Myeloma. The Experience of a Single Centre2010 | Publication without faculty affiliation
- Diagnistic a therapy of m. myeloma2009 | First Faculty of Medicine
Loading network view...